10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
56.09
-2.06 (-3.54%)
At close: Aug 14, 2026, 4:00 PM EDT
56.43
+0.34 (0.61%)
Pre-market: Aug 17, 2026, 8:17 AM EDT

10x Genomics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
7,3082,0641,7386,6154,17116,640
Market Cap Growth
332.60%18.74%-73.72%58.59%-74.93%9.21%
Enterprise Value
6,8351,6691,4266,3573,81516,120
Last Close Price
56.0916.3114.3655.9636.44148.96
PS Ratio
11.853.212.8510.698.0833.92
PB Ratio
8.852.592.458.935.1820.35
P/TBV Ratio
9.652.832.529.195.3621.13
P/FCF Ratio
60.1815.86----
P/OCF Ratio
57.5115.17260.86---
EV/Sales Ratio
11.082.602.3410.277.3932.86
EV/FCF Ratio
56.2812.83----
Debt / Equity Ratio
0.100.110.120.130.120.10
Debt / FCF Ratio
0.650.65----
Net Debt / Equity Ratio
-0.57-0.55-0.44-0.40-0.42-0.62
Net Debt / EBITDA Ratio
11.496.851.971.792.4215.90
Net Debt / FCF Ratio
-3.90-3.3754.254.602.034.12
Asset Turnover
0.610.660.650.620.500.50
Inventory Turnover
3.032.852.502.701.701.65
Quick Ratio
5.093.954.103.964.086.10
Current Ratio
5.694.464.974.694.856.77
Return on Equity (ROE)
-9.40%-5.78%-25.17%-32.98%-20.45%-7.48%
Return on Assets (ROA)
-5.05%-6.40%-12.84%-12.52%-9.99%-3.40%
Return on Capital Employed (ROCE)
-8.90%-11.30%-24.20%-23.80%-18.20%-5.80%
Earnings Yield
-1.03%-2.11%-10.51%-3.86%-3.98%-0.35%
FCF Yield
1.66%6.30%-0.33%-0.96%-3.96%-0.74%
Buyback Yield / Dilution
-4.39%-3.57%-2.80%-2.90%-3.18%-9.09%
SEC Filings: 10-K · 10-Q